UPDATE 1-First UK volunteer gets experimental GSK Ebola shot in trial

September 17, 2014 4:04 PM

8
0

LONDON, Sept 17 (Reuters) - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organisers said.

The candidate Ebola vaccine, which GSK co-developed with the U.S. National Institutes of Health, has also been given to 10 volunteers taking part in a similar separate trial in the United States, and so far there were no signs of any serious adverse reactions, doctors said.